Patent · US Active

Pharmaceutically active disubstituted pyridine derivatives

US9242937B2 · kind B2 · utility

4Cited by

0References

7Claims

0Family size

Assignees

Bayer Intellectual Property GmbH · DE
Lead Discovery Center GmbH · DE

Inventors

Gerd Ruhter · Hamburg, DE
Peter Nussbaumer · Schwanenstadt, AT
Axel Choidas · Herdecke, DE
Carsten Schulz-Fademrecht · Dortmund, DE
Bert Klebl · Dortmund, DE
Jan Eickhoff · Herdecke, DE

Key dates

Filing date	Mar 1, 2012
Grant date	Jan 26, 2016
Priority date	—
Expiry date	Mar 1, 2032

Classification

Technology area (CPC A)Human Necessities
CPC primaryA61P43/00
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The present invention relates to disubstituted pyridine derivatives and/or pharmaceutically acceptable salts thereof, the use of these derivatives as pharmaceutically active agents, especially for the prophylaxis and/or treatment of infectious diseases, including opportunistic diseases, immunological diseases, autoimmune diseases, cardiovascular diseases, cell proliferative diseases, inflammation, erectile dysfunction and stroke, and pharmaceutical compositions containing at least one of said disubstituted pyridine derivatives and/or pharmaceutically acceptable salts thereof. Furthermore, the present invention relates to the use of said disubstituted pyridine derivatives as inhibitors for a protein kinase.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.